Effect of the mTOR Inhibitor Everolimus on Angiogenic Biomarkers in Patients with Skin Lesions and Subependymal Giant Cell Astrocytoma (SEGA) Associated with Tuberous Sclerosis Complex (TSC)

被引：0
|
作者：
Franz, D. N.
Frost, M. N.
Prestifilippo, J.
Brechenmacher, T.
Jozwiak, S.
机构：
来源：
ANNALS OF NEUROLOGY | 2013年 / 74卷
关键词：
Brain tumors/oncology; Genetics;
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S135 / S135
页数：1
相关论文
共 50 条
  • [31] THE IMMUNOCHEMISTRY OF SUBEPENDYMAL GIANT-CELL ASTROCYTOMA (SEGA) IN TUBEROUS SCLEROSIS (TS)
    ALTERMATT, HJ
    LOPES, MBS
    SCHEITHAUER, BW
    VANDENBERG, SR
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1993, 52 (03): : 326 - 326
  • [32] Everolimus in the treatment of subependymal giant cell astrocytomas, angiomyolipomas, and pulmonary and skin lesions associated with tuberous sclerosis complex
    Franz, David Neal
    BIOLOGICS-TARGETS & THERAPY, 2013, 7 : 211 - 221
  • [33] LONG-TERM SAFETY AND EFFICACY RESULTS OF ORAL EVEROLIMUS IN PATIENTS WITH SUBEPENDYMAL GIANT CELL ASTROCYTOMAS (SEGA) IN TUBEROUS SCLEROSIS COMPLEX (TSC)
    Krueger, Darcy A.
    Care, Marguerite M.
    Holland, Katherine
    Agricola, Karen
    Tudor, Cynthia
    Byars, Anna
    Sahmoud, Tarek
    Franz, David N.
    NEURO-ONCOLOGY, 2011, 13 : 60 - 60
  • [34] Medical Management with mTOR Inhibitors vs. Surgical Resection: Comparison of Clinical Outcomes for Subependymal Giant Cell Astrocytoma (SEGA) in Tuberous Sclerosis Complex (TSC)
    Yoon, Susanne
    Ung, Nolan
    Mehta, Nehali
    Yang, Isaac
    Wu, Joyce
    Krueger, Darcy
    NEUROLOGY, 2013, 80
  • [35] The effect of everolimus on renal angiomyolipoma in patients with tuberous sclerosis complex being treated for subependymal giant cell astrocytoma
    Jozwiak, S.
    Belousova, E.
    Kingswood, C.
    Frost, M.
    Kuperman, R.
    Bebin, M.
    Korf, B.
    Flamini, R.
    Kohrman, M.
    Sparagana, S.
    Wu, J.
    Sahmoud, T.
    Shah, G.
    Franz, D.
    EUROPEAN UROLOGY SUPPLEMENTS, 2012, 11 (01) : E74 - U434
  • [36] Presurgical Administration of mTOR Inhibitors in Patients with Large Subependymal Giant Cell Astrocytoma Associated with Tuberous Sclerosis Complex
    Jiang, Tao
    Du, Jiang
    Raynald
    Wang, Junmei
    Li, Chunde
    WORLD NEUROSURGERY, 2017, 107 : 1053.e1 - 1053.e6
  • [37] Everolimus Treatment for an Early Infantile Subependymal Giant Cell Astrocytoma With Tuberous Sclerosis Complex
    Fukumura, Shinobu
    Watanabe, Toshihide
    Takayama, Rumiko
    Minagawa, Kimio
    Tsutsumi, Hiroyuki
    JOURNAL OF CHILD NEUROLOGY, 2015, 30 (09) : 1192 - 1195
  • [38] Response to everolimus in patients with giant cell astrocytoma associated to tuberous sclerosis complex
    Elena Mateos-Gonzalez, M.
    Lopez-Laso, Eduardo
    Vicente-Rueda, Josefina
    Camino-Leon, Rafael
    Fernandez-Ramos, Joaquin A.
    Auxiliadora Baena-Gomez, M.
    Jose Pena-Rosa, M.
    REVISTA DE NEUROLOGIA, 2014, 59 (11) : 497 - 502
  • [39] Population PK-PD Modeling of Everolimus in the Treatment of Patients with Tuberous Sclerosis Complex (TSC) Who Have Subependymal Giant Cell Astrocytomas (SEGA)
    Sallas, William
    Chiparus, Ovidiu
    Cheung, Wing
    Urva, Shweta
    Wang, Jixian
    Cauwel, Helene
    Lam, Du
    Shah, Gaurav
    Sarr, Celine
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2013, 40 : S40 - S41
  • [40] TSC1 Mosaicism Leading to Subependymal Giant Cell Astrocytoma but Not Tuberous Sclerosis Complex
    Hall, Adriana
    Westlake, Grant
    Short, Brittany Parker
    Pearson, Matthew
    Ess, Kevin C.
    PEDIATRIC NEUROLOGY, 2021, 123 : 38 - 39
12345